We develop, manufacture, sell complex generics and biosimilars: transplant products, hospital injectables (enoxaparin, azacitadine, glatiramer, ertapenem); depots (octreotide, risperidone, paliperidone, lanreotide; inhalation (fluticasone + salmeterol, formeterol + budesonide, mometasone); transdermals, topical aerosol foams, ophthalmics (cyclosporin), oral CR (mesalamines, methylphenidate, nifedipine), complex orals (deferasi...
We develop, manufacture, sell complex generics and biosimilars: transplant products, hospital injectables (enoxaparin, azacitadine, glatiramer, ertapenem); depots (octreotide, risperidone, paliperidone, lanreotide; inhalation (fluticasone + salmeterol, formeterol + budesonide, mometasone); transdermals, topical aerosol foams, ophthalmics (cyclosporin), oral CR (mesalamines, methylphenidate, nifedipine), complex orals (deferasirox, fingolimod, lanthanum, sevelamer carbonate, omega-3, dronedarone, temozolomide). Biosimilars launched 2015: adalimumab, rituximumab, trastuzumab, cetuximab, infliximab, etanercept, bevacizamab, EPO beta, FSH. Biosimilars launched 2017: abatacept, onabotulinumtoxinA, imiglucerase, alemtuzumab, omalizumab, palivizumab, denosumab, ofatumumab, ustekinumab, natalizumab, ranibizumab, tocilizumab, golimumab, certolizumab, eculixumab. Biosimilars launched now: PEGylated interferons, EPO alpha, PEGfilgrastim, beta interferons, darbepoetin, insulin, glargine, aspart, lispro.
